Kern Systems

Kern Systems is a private, pre-revenue biotech firm founded in 2018 and based in Allston, Massachusetts, focused on DNA data storage. The company's core platform translates digital bits (0s and 1s) into the molecular language of DNA (A, T, C, G) using a proprietary enzymatic synthesis approach, aiming to create a cost-effective, high-density, and long-lasting archival storage solution. With a leadership team featuring pioneers from Harvard, MIT, and the synthetic biology field, Kern is developing both the biochemical 'write' process and the necessary encoding/decoding software and hardware. The company targets the massive and growing market for cold data storage, where most data is rarely accessed but must be preserved for decades.

Enzymatic DNA synthesis platform for encoding digital data into synthetic DNA molecules for long-term archival data storage.

Kern competes in the emerging DNA data storage field against companies like Catalog (DNA-based computation and storage) and Iridia (nanopore-based storage), as well as large corporate R&D efforts from Microsoft and Twist Bioscience. Its key differentiation is its focus on proprietary enzymatic DNA synthesis, which it must prove can outperform both traditional chemical synthesis and competitors' alternative molecular approaches.